Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Quinacrine and Masoprocol

supplement:

Masoprocol

Research Papers that Mention the Interaction

Preincubation of cells with quinacrine , an inhibitor of phospholipase A2, or with the lipoxygenase inhibitors 5,8,11,14-eicosatetraynoic acid or nordihydroguaiaretic acid prior to thrombin challenge resulted in a concentration-dependent attenuation of the response.
The Journal of biological chemistry  •  1984  |  View Paper
Nordihydroguaiaretic acid (a lipoxygenase inhibitor) significantly potentiated the suppressive activity whereas quinacrine (a phospholipase A2 inhibitor) and indomethacin (a cyclooxygenase inhibitor) did not significantly affect it.
European journal of pharmacology  •  1992  |  View Paper
Combined pretreatment with quinacrine dihydrochloride and nordihydroguaiaretic acid almost completely abolished the S-ropivacaine-induced contraction.
Canadian journal of anaesthesia = Journal canadien d'anesthesie  •  2009  |  View Paper
Similarly, the phospholipase A2 inhibitor quinacrine (50 microM) and an inhibitor of AA metabolism, nordihydroguaiaretic acid ( NDGA ; 50 microM), reduced the GH responses to SKF38393, forskolin, and 8Br-cAMP.
General and comparative endocrinology  •  1996  |  View Paper
2 Nordihydroguäiaretic acid (NDGA; 5 × 10−6 m), an inhibitor of lipoxygenase and quinacrine (10−5 m), which blocks the release of arachidonic acid from phospholipids by inhibiting the enzyme phospholipase A2, blocked hypoxia‐induced contractions.
British journal of pharmacology  •  1991  |  View Paper
The relaxation produced by the inhibitory factor was unaffected by quinacrine and flurbiprofen while nordihydroguaiaretic acid potentiated the response.
British journal of pharmacology  •  1986  |  View Paper
Mepacrine , a phospholipase A2 inhibitor (3 X 10(-5) M) and the lipoxygenase inhibitor nordihydroguaiaretic acid (10(-5) M) inhibited this response whereas the cyclooxygenase inhibitor, diclofenac sodium (10(-5) M), and the thromboxane synthetase inhibitor imidazole (10(-5) M) did not.
European journal of pharmacology  •  1986  |  View Paper